Walgreens Boots Alliance Inc. (WBA) Given Outperform Rating at Robert W. Baird

walgreens-boots-alliance-inc-wba-given-outperform-rating-at-robert-w-baird.jpg

Walgreens Boots Alliance Inc. (NASDAQ:WBA)‘s stock had its “outperform” rating reissued by analysts at Robert W. Baird in a research report issued to clients and investors on Saturday. They presently have a $95.00 price target on the pharmacy operator’s stock. Robert W. Baird’s price objective points to a potential upside of 14.57% from the company’s previous close.
A number of other equities analysts also recently commented on the stock. Bank of America Corp. reaffirmed a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Tuesday, August 30th. Deutsche Bank AG lifted their target price on shares of Walgreens Boots Alliance from $93.00 to $94.00 and gave the stock a “buy” rating in a research note on Tuesday, August 30th. Keefe, Bruyette & Woods reaffirmed an “underperform” rating on shares of Walgreens Boots Alliance in a research note on Friday, July 22nd. Leerink Swann reaffirmed an “outperform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, August 30th. Finally, Credit Suisse Group AG reaffirmed an “outperform” rating and set a $95.00 target price (up from $80.71) on shares of Walgreens Boots Alliance in a research note on Thursday, September 1st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $93.13.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 82.92 on Friday. Walgreens Boots Alliance has a 52-week low of $71.50 and a 52-week high of $95.74. The company’s 50-day moving average is $81.40 and its 200-day moving average is $81.14. The stock has a market cap of $89.75 billion, a PE ratio of 28.65 and a beta of 1.01.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/10/walgreens-boots-alliance-inc-wba-given-outperform-rating-at-robert-w-baird.html

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. Walgreens Boots Alliance had a net margin of 2.70% and a return on equity of 15.56%. The company had revenue of $29.50 billion for the quarter. During the same period last year, the firm earned $1.02 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 2.4% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance will post $4.51 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 12th. Stockholders of record on Friday, August 19th will be given a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Wednesday, August 17th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. Walgreens Boots Alliance’s payout ratio is currently 51.90%.
In related news, Director William C. Foote sold 2,067 shares of the company’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $81.35, for a total value of $168,150.45. Following the completion of the sale, the director now owns 26,690 shares in the company, valued at approximately $2,171,231.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the company’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $83.00, for a total transaction of $2,464,685.00. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.
A number of hedge funds have added to or reduced their stakes in the stock. State Street Corp increased its stake in Walgreens Boots Alliance by 2.1% in the first quarter. State Street Corp now owns 36,198,072 shares of the pharmacy operator’s stock valued at $3,049,327,000 after buying an additional 746,698 shares during the period. Wellington Management Group LLP increased its stake in Walgreens Boots Alliance by 9.7% in the first quarter. Wellington Management Group LLP now owns 26,167,061 shares of the pharmacy operator’s stock valued at $2,204,313,000 after buying an additional 2,317,093 shares during the period. Norges Bank acquired a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $654,266,000. Geode Capital Management LLC increased its stake in Walgreens Boots Alliance by 3.0% in the first quarter. Geode Capital Management LLC now owns 7,602,662 shares of the pharmacy operator’s stock valued at $639,250,000 after buying an additional 223,243 shares during the period. Finally, Canada Pension Plan Investment Board increased its stake in Walgreens Boots Alliance by 602.0% in the first quarter. Canada Pension Plan Investment Board now owns 6,665,630 shares of the pharmacy operator’s stock valued at $561,513,000 after buying an additional 5,716,161 shares during the period. Hedge funds and other institutional investors own 59.87% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Be the first to comment on "Walgreens Boots Alliance Inc. (WBA) Given Outperform Rating at Robert W. Baird"

Leave a comment

Your email address will not be published.

*